Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |